Ares Financial Consulting
TWST icon

Ares Financial Consulting’s Twist Bioscience TWST Stock Holding History

Ares Financial Consulting’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$96K Hold
497
– – 0.07% 146
2026
Q2 		$51.1K Hold
497
– – 0.04% 226
2026
Q1 		$24.6K Buy
+497
New +$22.3K 0.02% 349

Other funds holding TWST

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
State of Michigan Retirement System
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Ares Financial Consulting's TWST Position: Q3 2026 in Review

Ares Financial Consulting held its Twist Bioscience (TWST) position steady in Q3 2026 at 497 shares worth $96K. The position accounts for 0.07% of the portfolio, ranked #146.

Ares Financial Consulting first reported a position in TWST in Q1 2026 and has held it in 3 quarters since. 155 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

  • Ares Financial Consulting held 497 shares of Twist Bioscience worth $96K as of Q3 2026.
  • Ares Financial Consulting left its Twist Bioscience share count unchanged in Q3 2026.
  • Twist Bioscience made up 0.07% of Ares Financial Consulting's portfolio in Q3 2026, its #146 holding.
  • Ares Financial Consulting first reported a position in Twist Bioscience in Q1 2026 and has held it in 3 quarters since.
  • 155 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.